CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(6.72) per share. This is a 87.04 percent increase over losses of $(51.86) per share from the same period last year.
- Headlines
- CNS Pharmaceuticals Q2 EPS $(6.72) Up From $(51.86) YoY
CNS Pharmaceuticals Q2 EPS $(6.72) Up From $(51.86) YoY
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
01:06
Putin discussed the Drone attack situation in Kazan with the Head of the Republic of Tatarstan.
01:04
USA President Biden: If needed, USA is always ready to provide assistance to Germany. USA stands with its allies to jointly combat violent terrorism.
00:43
The Kremlin: The future relationship between Russia and the USA will depend on the next statements from the USA government.